Skip to content
Home/GPs/Ryse Asset Management
Ryse Asset Management

Ryse Asset Management

London, United Kingdom·Founded 2017··ryseam.com

RYSE Asset Management LLP is a London-based, FCA-authorised early-stage venture capital firm investing in HealthTech across digital diagnostics, digital therapeutics, medical devices and health data platforms. Founded by clinicians, researchers and entrepreneurs, it backs companies between seed and Series A. Its RYSE Special Opportunities Fund, a USD 50m vehicle, announced its first close on 5 March 2024 with Future Care Capital as a cornerstone investor. The firm is registered at Companies House as an LLP (OC352409, incorporated 2010, brand relaunched 2017).

AUM
Funds
1
vintages 2024
Portfolio
6
Exits
0
SectorsHealthcare

Key facts

HQLondon, United Kingdom
Founded2017
Websiteryseam.com

Recent exits

No exits recorded yet.

Coverage notes

1 fund tracked, 6 portfolio companies (6 active · 0 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund Ryse Asset Management has raised, with its portfolio companies. Hand-checked from public filings.

1 fund
RYSE Special Opportunities FundVC
2024 · 2yr€46M6 active

Unrealized

6 held
BraingazeActive
HealthTechSpain· Entry 2024
HealthTechUnited States· Entry 2024
KnokActive
HealthTechPortugal· Entry 2020
HealthTechUnited Kingdom· Entry 2020
OtoActive
HealthTechUnited Kingdom· Entry 2022
BiotechUnited States· Entry 2026
Track Ryse Asset Management

Saved GPs appear in your watchlist, one click from your workspace.

About Ryse Asset Management

Ryse Asset Management is a British private equity and investment platform with capital deployed across 2 active fund vehicles, headquartered in London. The firm operates across multiple alternative strategies, with capital deployed into European businesses across TMT, consumer, healthcare, financials, industrials and energy.

Investment thesis

Ryse Asset Management operates across complementary alternative investment strategies, deploying capital into European businesses across TMT, consumer, healthcare, financials, industrials and energy. The multi-strategy platform enables diversified capital deployment across the business lifecycle from venture and growth equity to mid-cap buyouts, with capital sourced from institutional limited partners and selective family-office capital across the United Kingdom and broader European market.

Recent activity

Realised exits across the current platform vintages remain limited, with the portfolio in active deployment and value-creation phase. The platform tracks 2 fund vehicles, 37 active portfolio companies and 0 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.

Investment team

Senior partners. Hand-checked from public filings and the firm's own site.

Vivien de Tusch-Lec
General Partner · Strategy & Growth
Shabir Chowdhary
Founding Partner · Finance & Structuring
John Lee Allen
Partner · Healthcare
David Seemungal
Partner · Partnerships & Distribution
Last updated March 2026 · Sourced from public filings